ruxolitinib
novartis,incyte
['#mpn', 'ruxolitinib', 'mpnsm', 'rux,(-crux),(-trux),(-deruxtecan)']
ras mutations selection upon jak2 inhibition. a paradoxical oncogenic cooperation raising many clinical questions on managing ruxolitinib in #mpnsm. #ash22 
Physician scientist, hematologist & clinical pharmacologist #AML #MPN #CIC1427 @hopsaintlouis @univ_paris @inserm